Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FDJR8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,819
Award facts
- Contract value 100% obligated
- $18,819.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,819.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. The delivery order, issued on February 4, 2026, with an ultimate completion date of February 5, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. The prime contractor performs with no identified subcontractors, and this delivery order reflects the company's established performance capability in fulfilling specialized pharmaceutical requirements for federal military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FDJR8?
SPE2DR26FDJR8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FDJR8 worth?
The government has obligated $18,819 on SPE2DR26FDJR8.
Is contract SPE2DR26FDJR8 an order under another contract?
Yes. SPE2DR26FDJR8 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJR8 competed?
The extent of competition for SPE2DR26FDJR8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award